Viewing Study NCT05224102


Ignite Creation Date: 2025-12-25 @ 3:56 AM
Ignite Modification Date: 2026-02-24 @ 8:49 AM
Study NCT ID: NCT05224102
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-02
First Post: 2022-01-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema
Sponsor: Genentech, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ML43435
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators